
Daniel Albertson, MD
Division Chief: Anatomic Pathology and Molecular Oncology
Subspecialties: Genitourinary, gynecologic, breast, sarcoma, FISH, and autopsy pathology
Associate Professor (Clinical), University of Utah School of Medicine
Specialties
- Fish Pathology
- Breast
- Sarcoma pathology
- Genitourinary pathology
- Gynecologic pathology
Education
- Medical Degree—University of Nebraska
- Residency—Anatomic and Clinical Pathology, Creighton University
- Fellowship—Surgical Pathology, University of Utah
Certification/Affiliations
- United States and Canadian Academy of Pathology
- College of American Pathologists
Research Interests
- Oncologic genitourinary and gynecologic pathology
- Solid tumor FISH pathology
- Applications of digital pathology
Awards
- Hal Lankford Pathology Resident Award, University of Nebraska, 2011
- Outstanding Teaching Award in Anatomic Pathology, University of Utah, 2017
- The Joe Holden Award for Clinical Excellence in Anatomic Pathology, 2018
Recent Publications
- Stenehjem DD, et al. Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PLoS One. 2019;14(1):e0210415
- Gupta S, et al. Histone deacetylase inhibition has targeted clinical benefit in ARID1A-mutated advanced urothelial carcinoma. Mol Cancer Ther. 2019;18(1):185–95.
- Tward JD, et al. Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer Med. 2018;7(12):6030–9.
- Gupta S, et al. Comprehensive genomic sequencing of urothelial tumors identifies rare SMARCB1 (INI-1)-deficient carcinomas of the urinary system. Clin Genitourin Cancer. 2018;16(2):e373–82.
- Kuzman JA, et al. Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma. BMC Urol. 2017;17(1):1.